XB-064

N/A

Report date: 2024/01/25 10:30:03

Base Information

Drug NameXB-064

Drug Alias NameXB-064XB064

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionLeukocyte immunoglobulin-like receptor B1 inhibitors

TargetsLeukocyte immunoglobulin-like receptor B1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesExelixis Inc

China Registration ClassN/A

Active CompaniesExelixis Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A